Doctor’s Resources
2008 Conference On Buprenorphine
This conference on buprenorphine was a meeting to review the progress of buprenorphine prescribing in the United States. There are a number of lectures that were covered. I’ve listed the topics with direct links to their Powerpoint presentations in PDF form.
- Expansion of Services for Vermonters in Need of MAT for Opiate Dependence
- Buprenorphine in the Treatment of Opioid Addiction: Balancing Medication Access with Quality Care
- Buprenorphine: Balancing Access with Quality of Care
- Continuing Buprenorphine/Naloxone With Counseling Is More Effective Than Detoxification With Counseling for 15-21 Year Old Opioid Addicts
- Status Report: Research Needs
- Special Population Issues
- Subutex and Suboxone: How Much Is Prescribed vs. Abuse/Diversion Reports
- Buprenorphine in the Treatment of Opioid Addiction: Balancing Medication Access with Quality Care
- Buprenorphine: Balancing Access with Quality of Care—Opening Remarks
- Pilot Projects and Unmet Research Needs
- Education Status Report: Successes & Challenges
- Buprenorphine and pregnancy: Vermont program development and outcomes
- Emerging Clinical Challenges in Prescribing Buprenorphine
- Science-based Treatment of Opioid-Dependent Adolescents: Summary of Research & Research Needs
- Nurse Care Manager Model
- Integrating Buprenorphine Into an Abstinence Based, Ambulatory Treatment Program
- Status Report: Research Needs Using Buprenorphine to Treat Opioid Dependence During Pregnancy
- Toward optimal use of buprenorphine and methadone in treatment of heroin dependence
- Speciality Program Buprenorphine Induction: A Viable Means of Improving Diffusion into Office-Based Settings
- Physician Clinical Support System
- Drug Enforcement Administration
- Work Group Summaries
The American Association for the Treatment of Opioid Dependence
Their mission statement: The American Association for the Treatment of Opioid Dependence (AATOD) was founded in 1984 to enhance the quality of patient care in treatment programs by promoting the growth and development of comprehensive methadone treatment services throughout the United States. Click Here
The Substance Abuse and Mental Health Services Administration
The Substance Abuse and Mental Health Services Administration’s (SAMHSA) mission is to reduce the impact of substance abuse and mental illness on America’s communities. In order to achieve this mission, SAMHSA has identified 8 Strategic Initiatives to focus the Agency’s work on improving lives and capitalizing on emerging opportunities. Click Here
SAMHSA has a specific part of their site devoted to Buprenorphine: Click Here
Physician’s Clinical Support System-Buprenorphine
The PCSS-B is a collaborative project of the American Academy of Addiction Psychiatry (AAAP), the American Osteopathic Academy of Addiction Medicine (AOAAM) and the American Psychiatric Association (APA). Each organization is named in the Drug Addiction Treatment Act of 2000 (DATA 2000) as an organization that can provide training leading to waiver eligibility for physicians who want to offer office-based treatment of opioid dependence in their practices. Click Here
DATA 2000: Drug Addiction Treatment Act of 2000
